Walter Greenblatt, MBA

Chief Financial Officer

Walter Greenblatt is Chief Financial Officer of Thylacine Bio. He brings a vast store of business experience—both as an operating executive and an advisor to top management. After earning his MBA with Distinction from Harvard in 1982, he worked at Bain & Company, a leading strategy consulting firm. His projects included strategic planning, mergers & acquisitions, strategic cost analysis and marketing. He served clients in industries ranging from health care to financial services to manufacturing (including steel and oil industries). An experienced entrepreneur and “hands-on” operating executive, Mr. Greenblatt founded and grew a profitable business, ultimately managing over 130 employees. He successfully sold the business after operating it for ten years. His subsequent investment banking experience has focused on middle-market transactions. He has helped clients in a variety of healthcare and manufacturing industries to plan strategy, raise capital to implement the strategy and acquire and/or divest the business units necessary to achieve key goals.

Mr. Greenblatt received his MBA with Distinction from Harvard Business School in 1982. Previously he graduated summa cum laude from Yale and received a Masters degree in Economics with First Class Honors from Oxford University

More team members

Andrew Fradkin, JD
General Counsel
Mike McGinnis, MS, MBA
Head of Government Relations
Anne Moscona, MD
Ruth Karron, MD
Matteo Porotto, PhD
Elma Hawkins, PhD, MBA
Chairwoman of the Board
Fred Hayden, MD
Joan Fusco, PhD
Chief Development Officer
Tom Monath, MD
Chief Medical Officer
Sean Whelan, PhD
Allen Duplantier, PhD
Principal investigator
Daniel Graifman, MBA